The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhiren Shah & PACs

SUNIL CHINUBHAI SHAH Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat 01st September, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001, Maharashtra The Company Secretary & Compliance Officer, Parmax Pharma Ltd. Plot No. 20, Survey No. 52, Rajkot-Gondal National Highway No.27, Hadamtala, Tal. Kotda Sangani, Rajkot -360311, India Gujarat Scrip ID: PARMAX | Scrip Code: 540359 Dear Sir/Madam, Sub: Filing of report under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended ("SEBI Takeover Regulations") This is to inform you that Dhiren Chandulal Shah (“Acquirer 1”) and Sunil Chinubhai Shah (“Acquirer 2”), Dhairya Dhiren Shah (“PAC 1”), Hiren Pravin Doshi (“PAC 2”), Sheetal Hiren Doshi (“PAC 3”), Nirmal Sunilbhai Shah (“PAC 4”), Rupa Sunil Shah (“PAC 5”), Vijaykumar Natvarlal Shiyani (“PAC 6”) and Kamlesh Natvarlal Shiyani (“PAC 7”) Abhay Chinubhai Shah (“PAC 8”), Umang Alkesh Gosalia (“PAC 9”) and Meena Alkesh Gosalia (“PAC 10”), (collectively, the “Acquirers and PACs”) together considered under promoter and promoter group category, in terms of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (“SEBI (SAST) Regulations”), state that out of the total 31,37,586 equity shares, the Acquirers along with PAC 1 to PAC 9 have acquired 22,80,444 equity shares of face value of ₹10/- each, while the remaining 8,57,142 equity shares have been acquired by other public shareholders of the Parmax Pharma Limited (“Target Company”) pursuant to the preferential issue/allotment approved by the Target Company. Further, out of the total 21,45,145 warrants proposed to be issued pursuant to the Preferential Issue, 17,16,574 warrants have been allotted to the Acquirers along with PAC 1 to PAC 8, while the remaining 4,28,571 warrants have been allotted to other public shareholders of the Target Company, as and when the said warrants are exercised and converted into equity shares, in accordance with the terms and conditions of the preferential issue and applicable laws. The proposed preferential issue of equity shares and warrants was granted in-principle approval by BSE Limited vide its letter bearing reference no. LOD/PREF/DA/FIP/693/2026-27 dated August 21, 2026 and the same were allotted on August 29, 2026 by the Target Company. The acquisition of the aforesaid equity shares and warrants is being disclosed pursuant to Regulation 29(2) of the SEBI (SAST) Regulations, 2011. The details of the acquisition are as set out in the accompanying disclosure. This disclosure is being submitted in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. You are requested to kindly take the same on record and acknowledge receipt of this disclosure. Yours sincerely, Name: SUNIL SHAH Acquirer 2 SUNIL CHINUBHAI SHAH Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Parmax Pharma Limited Name of the Target Company (TC) Dhiren Chandulal Shah (“Acquirer 1”) and Name(s) of the acquirer and Persons Acting in Concert Sunil Chinubhai Shah (“Acquirer 2”) (PAC) with the acquirer Dhairya Dhiren Shah (“PAC 1”), Hiren Pravin Doshi (“PAC 2”), Sheetal Hiren Doshi (“PAC 3”), Nirmal Sunilbhai Shah (“PAC 4”), Rupa Sunil Shah (“PAC 5”), Vijaykumar Natvarlal Shiyani (“PAC 6”), Kamlesh Natvarlal Shiyani (“PAC 7”), Abhay Chinubhai Shah (“PAC 8”), Umang Alkesh Gosalia (“PAC 9”) and Meena Alkesh Gosalia (“PAC 10”) Whether the Acquirers & PACs belongs to Promoter/Promoter group BSE Limited (“BSE”) Name(s) of the Stock Exchange(s) where the shares of TC are Listed Number % w.r.t. total % w.r.t. total share / voting diluted Details of the acquisition / disposal as follows capital share/voting wherever capital of the TC applicable(*) (**) Before the acquisition under consideration, holding of : a) Shares carrying voting rights 21,70,164 58.01% (2) 58.01% b) Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others) - - - c) Voting rights (VR) otherwise than by shares - - - d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive - - - shares carrying voting rights in the T C (specify holding in each category) e) Total (a+b+c+d) 21,70,164 58.01%(2) 58.01% SUNIL CHINUBHAI SHAH Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat Details of acquisition/sale a) Shares carrying voting rights acquired/sold 22,80,444 25.27%(2) 25.27% b) VRs acquired /sold otherwise than by shares c) Warrants/convertible securities/any other 17,16,574 19.02%(2) 19.02% instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold d) Shares encumbered / invoked/released by the - - - acquirer e) Total (a+b+c+/-d) 39,97,018 44.29%(2) 44.29% After the acquisition/sale, holding of: a) Shares carrying voting rights 44,50,608 49.32%(2) 49.32% b) Shares encumbered with the acquirer - - - c) VRs otherwise than by shares - - - d) Warrants/convertible securities/any other 17,16,574 19.02%(2) 19.02% instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition 61,67,179 68.34% 68.34% e) Total (a+b+c+d) Preferential Allotment Mode of acquisition / sale (e.g. open market / off- market / public issue / rights issue / preferential allotment / inter-se transfer etc). August 29, 2026 Date of acquisition / sale of shares / VR or date of receipt of intimation of allotment of shares, whichever is applicable Number of Shares: 37,41,300 Equity share capital / total voting capital of the TC Amount (in ₹): 3,74,13,000 (Face Value of ₹ 10/- per before the said acquisition / sale equity share) Number of Shares: 68,78,886 Equity share capital/ total voting capital of the TC Amount (in ₹): 6,87,88,860 (Face Value of ₹ 10/- per after the said acquisition / sale equity share) Number of Shares: 90,24,031(1) Total diluted share/voting capital of the TC after Amount (in ₹): 9,02,40,310 (Face Value of ₹ 10/- per the said acquisition equity share) (*) Total share capital / voting capital to be taken as per the latest filing done by the company to the Stock SUNIL CHINUBHAI SHAH Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat Exchange under Clause 35 of the listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities / warrants into equity shares of the TC. (1) The 8,57,142 Equity Shares and 4,28,571 warrants have also been allotted to other Public Shareholders under the Proposed Preferential Issue. (2) Calculated as a percentage of the Expanded Voting Capital, which includes 52,82,731 Equity Shares issued pursuant to the Proposed Preferential Issue (assuming full conversion of Warrants) Signature of the acquirer / seller / Authorised Signatory Name: Sunil Shah Acquirer 2 Place: Rajkot, Gujarat Date: September 01, 2026 ******